Botulinum toxin A in the overactive bladder: current status and future directions

R Dmochowski, PK Sand - BJU international, 2007 - Wiley Online Library
Authors from America present a comprehensive review of botulinum toxin A in the overactive
bladder. The use of this agent in resistant cases is becoming more prevalent, and these …

Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A (BTX–A) for treatment of temporomandibular disorder

L Zhang, Q Liu, D Zou, L Yu - British Journal of Oral and Maxillofacial …, 2016 - Elsevier
Our aim was to evaluate the occlusal force and therapeutic efficacy of the masseteric
muscles after intramuscular injection of botulinum toxin A (BTX-A) for the treatment of …

Botulinum toxin therapy in children with neurogenic detrusor overactivity

JK Badawi - Turkish journal of urology, 2019 - pmc.ncbi.nlm.nih.gov
Special birth defects and neurological diseases can cause neurogenic detrusor overactivity
(NDO). First-line pharmacotherapy is the antimuscarinic therapy, which can be limited by …

Effectiveness of botulinum-A toxin for the treatment of refractory overactive bladder in children

A Marte, M Borrelli, MD Sabatino… - European journal of …, 2010 - thieme-connect.com
Aims: We describe our experience with botulinum-A toxin (BTX-A) in children presenting
idiopathic overactive bladder (OAB) refractory to anticholinergic drugs. Material and …

An evaluation of the efficacy of selective alpha-blockers in the treatment of children with neurogenic bladder dysfunction—preliminary findings

P Kroll, E Gajewska, J Zachwieja, M Sobieska… - International journal of …, 2016 - mdpi.com
The aim of this study was to assess the usefulness of selective α1-blockers in children with
neurogenic urinary tract dysfunctions and increased leak point pressure (LPP). 14 children …

[PDF][PDF] Complications of untreated and ineffectively treated neurogenic bladder dysfunctions in children: our own practical classification.

P Kroll, J Zachwieja - European Review for Medical & …, 2016 - europeanreview.org
Clean Intermittent Catheterization is mandatory if voiding is ineffective. Reduced bladder
capacity related to detrusor overactivity and decreased bladder walls compliance is …

Adolescence transitional care in neurogenic detrusor overactivity and the use of OnabotulinumtoxinA: A clinical algorithm from an Italian consensus statement

G Palleschi, G Mosiello, V Iacovelli… - Neurourology and …, 2018 - Wiley Online Library
Aims OnabotulinumtoxinA (onaBNTa) for treating neurogenic detrusor overactivity (NDO) is
widely used after its regulatory approval in adults. Although the administration of onaBNTa is …

Urological problems in patients with meningomyelocele: Diagnostic studies and management

R Stein, A Schröder, R Beetz, A Ermert, D Filipas… - Der Urologe, 2007 - Springer
Zusammenfassung Die Behandlung von Kindern und Jugendlichen mit Meningomyelozele
hat in den letzten 30 Jahren einen deutlichen Wandel erfahren. Die Etablierung der …

Botulinumtoxin in der Therapie der überaktiven Blase-ein Überblick

C Seif, S Boy, B Wefer, R Dmochowski… - … Urologe. Ausg. A …, 2008 - search.proquest.com
Dieser Reviewartikel soll einen Überblick über den momentanen Stand in der Behandlung
der neurogenen und idiopathischen Detrusorüberaktivität durch Botulinumtoxin-A …

Botulinum toxin-A injections in children with neurogenic bladder

P Kroll, A Jankowski, J Soltysiak, M Murias… - Nephro-Urology …, 2011 - brieflands.com
: Background: Botulinum-A toxin (BTX) administration appears to be useful in patients with
high pressure neurogenic bladder. Objectives: The aim of this study was to evaluate the …